27.07.2013 Views

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

alleles are especially vulnerable to environmental exposures. <strong>The</strong> murine viable yellow<br />

agouti (A vy ) locus is a well-established metastable epiallele that serves as an epigenetic<br />

biosensor. Using this model, we previously reported that maternal exposure<br />

to bisphenol A (BPA), the monomer forming polycarbonate plastic and epoxy<br />

resins, decreases DNA methylation at the A vy locus. Herein, we assess global DNA<br />

methylation levels as well as novel murine metastable epiallele methylation patterns<br />

in order to identify additional epigenetic loci sensitive to maternal BPA exposure.<br />

DNA from d22 liver was isolated from A vy /a and a/a mice exposed in utero and<br />

during lactation to 50 mg BPA/kg diet (N=90) or a control diet (N=76). Global<br />

methylation levels were assessed via the Luminometric Methylation Assay, and<br />

DNA methylation at candidate metastable epialleles Dnajb1 and Glcci1 was analyzed<br />

via bisulfite sequencing. Global DNA methylation levels were significantly<br />

higher in BPA-exposed mice compared to controls (70.4% and 66.4%, respectively;<br />

p-value=0.001). Mean Glcci1 methylation levels at two intracisternal A particle<br />

(IAP) repeats were higher in BPA exposed mice (95.2% and 91.3%) compared to<br />

controls (93.7% and 89.9%; p-value= 0.001). No exposure differences were observed<br />

in the promoter <strong>of</strong> Dnajb1, which exhibited low levels <strong>of</strong> methylation in<br />

both groups. Both global and site-specific methylation changes may be useful toxicological<br />

tools as epigenetic biosensors <strong>of</strong> environmental exposure and aid in evaluating<br />

disease susceptibility.<br />

101 IDENTIFICATION OF CANCER SPECIFIC<br />

METHYLATED PROMOTER REGION IN MOUSE BONE<br />

MARROW ORIGINATED TUMOR CELLS.<br />

H. Shin 1 , S. Jeong 2 , J. Kang 1 , Y. Park 1 , S. Son 1 and H. Kang 1 . 1 <strong>Toxicology</strong> &<br />

Chemistry Division, NVRQS, Anyang, Republic <strong>of</strong> Korea and 2 GLP Research Center,<br />

College <strong>of</strong> Natural Sciences, Hoseo University, Asan City, Republic <strong>of</strong> Korea.<br />

DNA methylation has pr<strong>of</strong>ound roles in gene regulation and is known as contributing<br />

factors in disease and cancer. In cancer cells, abnormal methylation <strong>of</strong><br />

CpG islands has been widely described. <strong>The</strong> etiology <strong>of</strong> bone marrow originated<br />

cancer is still largely unknown, but exposure to chemicals has been suggested to be<br />

cancer risk factors and associated with the pathologies. <strong>The</strong> aim <strong>of</strong> this study is to<br />

identify commonly altered methylation genes in mouse bone marrow originated<br />

cancer cells compared to normal bone marrow cell for the application <strong>of</strong> prescreening<br />

tool to the bone marrow carcinogenicity <strong>of</strong> chemicals. Normal bone marrow<br />

cells were obtained from 8 weeks old male balb/c mice and 2PK, EL4 and M1 were<br />

used as representatives <strong>of</strong> bone marrow cancer cells. Sheared DNA was immunopricipitated<br />

with 5-methylcitosine antibody followed by LM (ligation-mediated)<br />

PCR. Amplified DNA were labeled with fluorescence and hybridized to mouse<br />

105K methylation chip (Agilent). Total RNA was isolated from each cell and reverse-transcripted<br />

to cDNA. Expression <strong>of</strong> mRNA was analyzed by real time PCR.<br />

Sodium bisulfite treated DNA was amplified and pyrosequencing analysis was conducted<br />

using PSQ96MA system. We identified commonly hypermethylated genes<br />

such as ABI2, FGF3, BCL11a, STAGE2 and hypomethylated genes like SLMO1<br />

and PNMA2 in promoter regions compared to those <strong>of</strong> normal bone marrow cells.<br />

Hypermethylated genes in promoter region also showed reduced mRNA expression<br />

except ABI2 and hypomethylated gene, SLMO1, was represented hyperexpression<br />

<strong>of</strong> its mRNA in cancer cells. To validate the result <strong>of</strong> BCL 11a, we did pyrosequencing<br />

analysis <strong>of</strong> Bcl11a, which results showed similar pattern <strong>of</strong> our previous<br />

microarray data. We expect that this altered methylation genes could be very useful<br />

for diagnosis index bone marrow originated cancers in experimental animals and<br />

used as prescreening tools for the bone marrow related carcinogenic evaluation <strong>of</strong><br />

chemicals.<br />

102 DOSE-DEPENDENT SHIFTS IN A VY COAT COLOR<br />

DISTRIBUTION FOLLOWING MATERNAL DIETARY<br />

EXPOSURE TO BISPHENOL A.<br />

O. S. Anderson, M. Nahar, T. R. Jones and D. C. Dolinoy. Environmental<br />

Health Science, University <strong>of</strong> Michigan, Ann Arbor, MI.<br />

Environmental exposures and nutritional status in utero influence epigenetic mechanisms<br />

shaping disease susceptibility throughout the life-course. Metastable epialleles<br />

are alleles variably expressed due to epigenetic modifications established early in<br />

development. <strong>The</strong> murine viable yellow agouti (A vy ) locus is a metastable epiallele<br />

that results in coat color varying from yellow (unmethylated) to pseudoagouti<br />

(methylated) due to stochastic methylation <strong>of</strong> cytosine-guanine dinucleotides<br />

among isogenic mice. In yellow mice, constitutive ectopic Agouti expression results<br />

in adverse effects including diabetes and adult-onset obesity. Bisphenol A (BPA), a<br />

high production-volume chemical in polycarbonate plastic and epoxy resins, is<br />

found in consumer products such as food and water containers, receipts, and metal<br />

can linings. Utilizing the A vy mouse model, we evaluated dose-dependent maternal<br />

dietary BPA exposure and its impact on coat color distribution, an epigenetic<br />

biosensor for altered DNA methylation status. At d22, A vy /a <strong>of</strong>fspring <strong>of</strong> mothers<br />

exposed to a diet <strong>of</strong> 50 mg/kg (n=9 litters), 50 mcg/kg (n=7 litters), or 50 ng/kg<br />

(n=8 litters) BPA throughout gestation and lactation were visually rated for coat<br />

color status. Replicating previously reported data from our group (Dolinoy et. al.<br />

PNAS, 2007), maternal dietary exposure to 50 mg/kg shifts the coat color distribution<br />

<strong>of</strong> Avy/a <strong>of</strong>fspring toward the yellow coat color phenotype compared to <strong>of</strong>fspring<br />

<strong>of</strong> mothers consuming a control corn oil diet (n=11 litters; p-value=0.004).<br />

Conversely, maternal dietary exposure to 50 mcg/kg or 50 ng/kg BPA displays a significant<br />

shift toward the pseudoagouti coat color phenotype compared to a corn oil<br />

control diet (p-value=0.0036, and 0.0001, respectively). Thus far these results suggest<br />

BPA alters A vy epigenetic regulation in a non-monotonic fashion, indicating<br />

varying exposure levels early in development may modify the epigenome, which<br />

consequently influences disease susceptibility throughout life.<br />

103 THE UP-REGULATION OF AHR AND STAT1 GENE<br />

EXPRESSION IN LONG-TERM ESTROGEN EXPOSED<br />

MCF-7 CELLS: POTENTIAL ROLES OF AUTOCRINE<br />

SIGNALING AND EPIGENETIC MECHANISMS.<br />

N. A. Englert 1, 2 , B. C. Spink 1 and D. C. Spink 1, 2 . 1 Laboratory <strong>of</strong> Molecular<br />

<strong>Toxicology</strong>, Wadsworth Center, New York State Department <strong>of</strong> Health, Albany, NY<br />

and 2 Department <strong>of</strong> Environmental Health Sciences, State University <strong>of</strong> New York at<br />

Albany, Albany, NY.<br />

<strong>The</strong> aryl hydrocarbon receptor (AhR) regulates expression <strong>of</strong> cytochromes<br />

P4501A1 and 1B1, enzymes that catalyze metabolism and bioactivation <strong>of</strong> numerous<br />

xenobiotics and endobiotics. Signal transducer and activator <strong>of</strong> transcription 1<br />

(STAT1) mediates the effects <strong>of</strong> interferons, regulates expression <strong>of</strong> immune-response<br />

genes, potentiates pro-survival signals, and its elevated expression in tumors<br />

appears to provide a growth advantage. We observed that both AhR and STAT1 are<br />

up-regulated in long-term estrogen exposed (LTEE) MCF-7 breast cancer cells that<br />

were obtained by continuous exposure to 1 nM 17β-estradiol (E2). LTEE cells also<br />

showed increased levels <strong>of</strong> phosphorylated STAT1. To determine the persistence <strong>of</strong><br />

the up-regulation <strong>of</strong> STAT1 and AhR expression in LTEE cells, we examined their<br />

expression in LTEE cultures after the removal <strong>of</strong> added E2. Our results indicate<br />

that STAT1 expression relies on the continued presence <strong>of</strong> E2, since total STAT1<br />

levels returned to near control levels after E2 withdrawal, with a half-life <strong>of</strong> about 9<br />

days. STAT1 expression paralleled the level <strong>of</strong> activation <strong>of</strong> the MAP kinase pathway,<br />

a known effector <strong>of</strong> STAT1. Increased steady-state ERK1/2 phosphorylation<br />

was observed in LTEE cells, but this decreased after E2 removal. Conversely, the elevated<br />

expression <strong>of</strong> AhR showed no reversion toward control levels after 35 days <strong>of</strong><br />

E2 withdrawal. <strong>The</strong> up-regulation <strong>of</strong> AhR expression was coincident with alterations<br />

in histone methylation as determined by chromatin immunoprecipitation,<br />

and was reflected in marked changes in AhR-regulated CYP1A1 inducibility. <strong>The</strong>se<br />

studies indicate that LTEE alters AhR- and STAT1-regulated processes, and that divergent<br />

epigenetic and autocrine signaling mechanisms may be involved in their<br />

regulation.<br />

104 EPIGENETIC INACTIVATION OF P16 INK4A GENE IS<br />

ASSOCIATED WITH RESISTANCE OF GUERIN<br />

CARCINOMAS TO DOXORUBICIN AND CISPLATIN.<br />

S. Sarfaraz 1 , S. Shpyleva 1 , I. Todor 2 , N. Yanova 2 , V. Chekhun 2 and I. Pogribny 1 .<br />

1 Biochemical <strong>Toxicology</strong>, NCTR/FDA, Jefferson, AR and 2 Oncology and Radiobiology,<br />

R.E. Kavetsky Institute <strong>of</strong> Experimental Pathology, Kyiv, Ukraine. Sponsor: V.<br />

Tryndyak.<br />

Acquired drug resistance is a major clinical obstacle in the treatment <strong>of</strong> cancer patients.<br />

<strong>The</strong>refore, understanding the underlying molecular mechanisms associated<br />

with its development is <strong>of</strong> prime importance. In the present study, we examined the<br />

role <strong>of</strong> epigenetic alterations in transplantable Guerin carcinoma resistant to either<br />

Doxorubicin (DOX) or Cisplatin (cisDDP), two cancer chemotherapeutic drugs<br />

with different modes <strong>of</strong> action. Despite this difference, Dox- and cisDDP-resistant<br />

Guerin tumors displayed similar alterations in expression <strong>of</strong> most common cancerrelated<br />

genes. <strong>The</strong>se changes include down-regulation <strong>of</strong> Tp53, Pten, Brca1, and<br />

Cdkn2a(p16 INK4a ) genes and up-regulation <strong>of</strong> Fos, Vegfa, Vegfc, Plaur, and S100a4<br />

genes. Additionally, both drug-resistant Guerin tumors were characterized by similar<br />

epigenetic changes showing pronounced DNA hypermethylation. This was evidenced<br />

by the 63% increase in gene-specific CpG island methylation in resistant<br />

SOT 2011 ANNUAL MEETING 21

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!